We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
利妥昔单抗注射液联合化疗治疗 B 细胞非霍奇金淋巴瘤的疗效观察.
- Authors
周婕; 青胜兰; 徐锋; 张娜; 刘元军
- Abstract
Objective: To observe the efficacy of Rituximab injection combined with chemotherapy in the treatment of B-cell Non-Hodgkin Lymphoma (B-NHL). Methods: 71 cases of patients with B-NHL treated in our hospital from January 2013 to December 2014 were divided into control group (n=35) and observation group (n=36), the control group was treated with conventional chemotherapy,while the observation group was treated with Rituximab injection combined with chemotherapy, evaluated the clinical efficacy and safety of two groups after 3 cycles treatment. Results: Total effective rate of observation group was 91.67%, which was significantly higher than 68.57% in control group, the difference was statistically significance (x2=5.979, P<0.05); Total incidence of adverse reactions in observation group was 41.67%, which was slightly lower than 45.71% in control group, but the difference was not statistically significant (x2=0.118, P>0.05). Conclusion: Rituximab injection combined with chemotherapy has remarkable mid-term efficacy in the treatment of B-NHL, and without serious adverse reaction, which is worthy of application.
- Publication
Progress in Modern Biomedicine, 2015, Vol 15, Issue 31, p6143
- ISSN
1673-6273
- Publication type
Article
- DOI
10.13241/j.cnki.pmb.2015.31.039